Cognitive Rehabilitation and Exposure Therapy for Geriatric Hoarding
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Feb 22, 2022
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Hoarding disorder (HD) is a chronic, progressive, and debilitating psychiatric condition that leads to devastating personal and community consequences, particularly for older adults. HD is defined by persistent difficulty discarding or parting with possessions due to distress associated with discarding, urges to save, and/or difficulty making decisions about what to keep and what to discard. As a result, clutter accumulates and fills active living areas, preventing the normal use of space and resulting in distress and disability. Community epidemiological reports estimate the prevalence of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults age 50 and older
- • voluntary informed consent for participation
- • DSM-5 diagnosis of HD
- • HD as a primary, most severe diagnosis
- • stable on medications for at least 8 weeks
- Exclusion Criteria:
- • current psychosis or mania as measured by the Mini-International
- • current or history of any neurodegenerative disease
- • substance use disorder
- • current use of benzodiazepine medication
- • suicidality
- • current participation in exposure-based therapy
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Catherine Ayers, PhD
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials